IL6 and COVID-19: The study conducted by Gao et al. (2020) revealed significant differences between mild and severe COVID-19 cases in terms of interleukin-6 (IL-6), d-dimer (d-D), glucose, fibrinogen, thrombin time, and C-reactive protein levels [11].